1. Home
  2. PAVS vs IKNA Comparison

PAVS vs IKNA Comparison

Compare PAVS & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAVS
  • IKNA
  • Stock Information
  • Founded
  • PAVS 2004
  • IKNA 2016
  • Country
  • PAVS United States
  • IKNA United States
  • Employees
  • PAVS N/A
  • IKNA N/A
  • Industry
  • PAVS Medicinal Chemicals and Botanical Products
  • IKNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAVS Health Care
  • IKNA Health Care
  • Exchange
  • PAVS Nasdaq
  • IKNA Nasdaq
  • Market Cap
  • PAVS 90.2M
  • IKNA 81.6M
  • IPO Year
  • PAVS 2019
  • IKNA 2021
  • Fundamental
  • Price
  • PAVS $1.38
  • IKNA $1.49
  • Analyst Decision
  • PAVS
  • IKNA Buy
  • Analyst Count
  • PAVS 0
  • IKNA 2
  • Target Price
  • PAVS N/A
  • IKNA $3.00
  • AVG Volume (30 Days)
  • PAVS 9.8K
  • IKNA 169.0K
  • Earning Date
  • PAVS 01-01-0001
  • IKNA 03-11-2025
  • Dividend Yield
  • PAVS N/A
  • IKNA N/A
  • EPS Growth
  • PAVS N/A
  • IKNA N/A
  • EPS
  • PAVS N/A
  • IKNA N/A
  • Revenue
  • PAVS $6,544,819.00
  • IKNA $659,000.00
  • Revenue This Year
  • PAVS N/A
  • IKNA N/A
  • Revenue Next Year
  • PAVS N/A
  • IKNA N/A
  • P/E Ratio
  • PAVS N/A
  • IKNA N/A
  • Revenue Growth
  • PAVS N/A
  • IKNA N/A
  • 52 Week Low
  • PAVS $0.32
  • IKNA $1.22
  • 52 Week High
  • PAVS $2.48
  • IKNA $1.94
  • Technical
  • Relative Strength Index (RSI)
  • PAVS 59.12
  • IKNA 48.35
  • Support Level
  • PAVS $1.32
  • IKNA $1.40
  • Resistance Level
  • PAVS $1.45
  • IKNA $1.60
  • Average True Range (ATR)
  • PAVS 0.06
  • IKNA 0.07
  • MACD
  • PAVS -0.01
  • IKNA 0.01
  • Stochastic Oscillator
  • PAVS 53.33
  • IKNA 47.62

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

Share on Social Networks: